Cetera Advisor Networks’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Cetera Advisor Networks’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-361	Closed	-$3.28K	–	2738
2023 Q1	$3.28K	Hold	361	–	–	﹤0.01%	2578
2022 Q4	$4.23K	Hold	361	–	–	﹤0.01%	2524
2022 Q3	$8K	Hold	361	–	–	﹤0.01%	2065
2022 Q2	$9K	Sell	361 -216	-37%	-$7.35K	﹤0.01%	2045
2022 Q1	$29K	Sell	577 -34	-6%	-$1.68K	﹤0.01%	2029
2021 Q4	$43K	Buy	611 +34	+6%	+$2.87K	﹤0.01%	2008
2021 Q3	$54K	Sell	577 -17	-3%	-$1.61K	﹤0.01%	1930
2021 Q2	$60K	Hold	594	–	–	﹤0.01%	1867
2021 Q1	$55K	Hold	594	–	–	﹤0.01%	1462
2020 Q4	$49K	Hold	594	–	–	﹤0.01%	1335
2020 Q3	$51K	Sell	594 -33	-5%	-$3.85K	﹤0.01%	1222
2020 Q2	$58K	Sell	627 -660	-51%	-$36.4K	﹤0.01%	1820
2020 Q1	$37K	Hold	1,287	–	–	﹤0.01%	1097
2019 Q4	$54K	Buy	1,287 +627	+95%	+$13.7K	﹤0.01%	1224
2019 Q3	$9K	Hold	660	–	–	﹤0.01%	1195
2019 Q2	$23K	Buy	+660	New	+$35.8K	﹤0.01%	1183

Other funds holding VBIV

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cetera Advisor Networks's VBIV Position: Q2 2023 in Review

Cetera Advisor Networks sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q2 2023, closing a stake of 361 shares — an estimated $3.28K sold.

Cetera Advisor Networks first reported a position in VBIV in Q2 2019 and held it in 16 quarters. The position peaked at $60K in Q2 2021. 46 funds tracked by Wall St. Rank hold VBIV as of Q2 2023.

Cetera Advisor Networks reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q2 2023 after selling out during the quarter.
Cetera Advisor Networks sold 361 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q2 2023, an estimated $3.28K.
Cetera Advisor Networks first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2019 and held it in 16 quarters.
Cetera Advisor Networks's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $60K in Q2 2021.
46 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q2 2023.

Based on Cetera Advisor Networks's 13F filing for Q2 2023, filed 10 Aug 2023.